Onward Medical announced today that it submitted a de novo application to the FDA for the approval of its ARC-EX spinal cord stimulation system. The Eindhoven, the Netherlands-based company designed ARC-EX to restore function of upper extremities after spinal cord injury (SCI). If approved, the company says ARC-EX would become the first ever SCS therapy […]
Onward Medical
Onward raises $22M to support neurostim tech
Onward Medical announced today that it successfully raised $21.8 million (€20 million) in gross proceeds through a private placement. The company offered more than 4.4 million new ordinary shares at an issue price of $4.89 (€4.50) per share. It completed the offering with participation from institutional investors, certain founders and management and members of the […]
FDA accepts Onward BCI into advisory program
Onward Medical announced today that the FDA accepted it into its new Total Product Lifecycle Advisory Program (TAP) — a move that could boost the development of Onward’s BCI technology. Acceptance into the TAP program comes on the heels of FDA breakthrough device designation for the ARC-BCI system last month. Breakthrough device designation is a […]
Onward wins FDA breakthrough nod for use of neurostim with brain-computer interface
Onward Medical announced today that the FDA granted breakthrough device designation for its ARC-BCI system that uses brain-computer interface (BCI) technology. ARC-BCI uses BCI technology in conjunction with ARC-IM neurostimulation. It aims to restore thought-driven lower limb mobility after spinal cord injury (SCI). The BCI system uses AI to decode brain signals and translate them […]
Onward begins neurostim study to address post-spinal cord injury hemodynamic instability
Onward Medical announced today that it began the HemON NL clinical feasibility study to evaluate its ARC-IM neurostimulation therapy. Onward said that, in late 2023, a study participant received the investigational ARC-IM neurostimulator and lead implant. This study aims to assess the safety and effectiveness of the therapy to address hemodynamic instability after spinal cord […]
5 more brain-computer interface companies you need to know
The brain-computer interface (BCI) space continues to rise in notoriety, and a number of players are throwing their hats in the ring. Such technologies could enable users to control a computer with their brain, or even go beyond that. Countless immobile people someday could control a mouse cursor, keyboard, mobile device/tablet, wheelchair or prosthetic device […]
Onward spinal cord stimulation demonstrates improved mobility in study
Onward Medical announced a new publication demonstrating the impact of its ARC therapy to address gait challenges related to Parkinson’s disease. Eindhoven, the Netherlands-based Onward designed its ARC-IM stimulation system to deliver targeted, programmed therapy to the spinal cord. It aims to restore movement and other functions after spinal cord injury. The study, published in Nature […]
How Onward uses spinal cord stimulation — and perhaps BCI — to restore movement
The brain-computer interface space has taken medtech by storm. This novel approach from Onward has the potential to bring it to another level. Several companies are developing brain-computer interfaces (BCIs), many of which offer people with paralysis a chance to control external devices with their mind. Onward, a Dutch medtech company, develops technology that could […]
Onward announces first-in-human implant of stimulator with BCI
Onward Medical announced today that it completed the first-in-human implant of its ARC-IM stimulator for restoring upper extremity function. Eindhoven, The Netherlands-based Onward designed the stimulator to restore function after spinal cord injury (SCI). The patient also received a wireless brain-computer interface (BCI) for initiating thought-driven movement when paired with ARC-IM. Onward’s ARC-IM delivers targeted, […]
Research supports brain-computer interface tech from Onward
Onward Medical announced today that published data demonstrates the ability of its wireless brain-computer interface (BCI). The data, published in Nature, demonstrates how the BCI uses thought to modulate ARC therapy. Researchers say that, when paired with ARC therapy, an implanted BCI allowed an individual to gain augmented control over when and how he moved […]
Onward completes first-in-human use of movement-restoring lead
Onward Medical announced today that it successfully completed the first-in-human use of its investigational ARC-IM lead. Eindhoven, the Netherlands-based Onward designed the lead to restore movement, function and independence in people with spinal cord injury (SCI). The company developed ARC-IM to deliver targeted electrical pulses to the spinal cord. It represents a key component of […]